Clinical Report: PET Imaging Agents for Localizing Parathyroid Glands in pHPT

Overview

This systematic review and meta-analysis evaluated PET tracers for localizing pathological parathyroid glands in primary hyperparathyroidism (pHPT). The tracer l-(11C)Methionine (11C-MET) demonstrated promising sensitivity and positive predictive value (PPV) for accurate gland localization, potentially improving surgical outcomes.

Background

Primary hyperparathyroidism is a common endocrine disorder characterized by elevated serum calcium and parathyroid hormone levels, most often caused by a single adenoma. Minimally invasive parathyroidectomy (MIP) is preferred over conventional exploration due to reduced operative time and complications. Accurate preoperative imaging is critical for successful MIP, with 99Tc-sestamibi SPECT-CT being standard but limited by moderate sensitivity. PET imaging offers higher spatial resolution and may improve localization, but the optimal tracer remains unclear.

Data Highlights

Key Findings

• 11C-MET is the most extensively studied PET tracer for parathyroid localization in pHPT.
• Meta-analysis showed pooled sensitivity and PPV of 11C-MET for correct quadrant localization of pathological glands.
• PET imaging offers superior spatial and temporal resolution compared to SPECT, potentially detecting smaller adenomas.
• Not all PET tracers are suitable due to factors like tracer half-life and parathyroid specificity.
• Second-line imaging modalities such as MRI and CT have variable performance and are used when first-line imaging is inconclusive.
• Quality assessment of included studies was performed using the QUADAS-2 tool to ensure methodological rigor.

Clinical Implications

Incorporating 11C-MET PET imaging into the diagnostic pathway for pHPT may enhance preoperative localization accuracy, facilitating minimally invasive parathyroidectomy. Clinicians should consider tracer characteristics and institutional capabilities when selecting PET agents. PET imaging may be particularly valuable in cases with equivocal or negative first-line imaging results.

Conclusion

PET imaging, especially with 11C-MET, represents a promising modality for localizing pathological parathyroid glands in pHPT, potentially improving surgical planning and outcomes. Further standardized studies are warranted to optimize tracer selection and imaging protocols.

References

1. W.P. Kluijfhout et al. 2016 -- Evaluation of PET Imaging Agents for Localizing Parathyroid Glands: A Comprehensive Review and Meta-Analysis